Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes
about
Alexander diseaseBlood-CNS Barrier Impairment in ALS patients versus an animal modelAstrocytes acquire resistance to iron-dependent oxidative stress upon proinflammatory activationAstrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy.Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?Astrocyte Dysfunction in Developmental Neurometabolic Diseases.Proteomic analysis reveals differentially regulated protein acetylation in human amyotrophic lateral sclerosis spinal cord.Transcriptomic analysis and 3D bioengineering of astrocytes indicate ROCK inhibition produces cytotrophic astrogliosis.Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo.Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction.Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosisWnt Signaling Alteration in the Spinal Cord of Amyotrophic Lateral Sclerosis Transgenic Mice: Special Focus on Frizzled-5 Cellular Expression PatternChanges in Protein Expression and Lysine Acetylation Induced by Decreased Glutathione Levels in AstrocytesHigh-Throughput Phenotypic Screening of Human Astrocytes to Identify Compounds That Protect Against Oxidative Stress.Electrophilic nitro-fatty acids prevent astrocyte-mediated toxicity to motor neurons in a cell model of familial amyotrophic lateral sclerosis via nuclear factor erythroid 2-related factor activationExpression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice.Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis.Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods.Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach.Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats.The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis.Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers.Suppression of Basic Fibroblast Growth Factor Expression by Antisense Oligonucleotides Inhibits Neural Stem Cell Proliferation and Differentiation in Rat models With Focal Cerebral Infarction."Targeting astrocytes in CNS injury and disease: A translational research approach".Astrocytes and synaptic plasticity in health and disease.Altered astrocytic response to activation in SOD1(G93A) mice and its implications on amyotrophic lateral sclerosis pathogenesis.New insights into SMA pathogenesis: immune dysfunction and neuroinflammation.Non-autonomous Cellular Responses to Ototoxic Drug-Induced Stress and Death.Imaging of glia activation in people with primary lateral sclerosis.When too much ATP is a bad thing: a pivotal role for P2X7 receptors in motor neuron degeneration.Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis.Deletion of Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death.DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis.Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage.Astroglial transcriptome dysregulation in early disease of an ALS mutant SOD1 mouse model.Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury.
P2860
Q24633313-86CE1737-19FD-4E18-A1BB-BFAB504B58CBQ27026792-EF1C937A-E1E7-4EB5-8799-029ACDD0AFABQ28393397-4907A7AF-BDBF-48F6-9A74-A107F5C98C60Q30537986-8B1B6D9A-68A2-4A8E-90BF-B46B686DED3DQ30843477-A7ED6AA8-6C5F-49AF-B4C5-0A53B6289894Q33767845-D6117199-8C0F-47B7-B3C7-58DABCA1570DQ34679071-0ABBA2DF-BA25-4E8E-B34F-1171BA8589FDQ35061120-26DE0F52-42A9-44FF-A689-6D3BB302EE95Q35103816-7F2F9E71-B090-48E7-A179-1D5AA59D5B95Q35471228-CD5B63AB-BC18-4DCB-88CE-F2E34C4032FDQ35487248-D03766D2-5807-4E01-8845-2F1B0E932063Q35726226-91382F9F-785A-419C-9A5C-1E18EECAFF79Q36021420-2D612224-4680-4C39-8B1F-1EAF75814C15Q36539478-08D67FBD-C127-4E0D-B1F9-3C5DB381CA0EQ36808557-9FC893DB-3E62-4E88-8373-2B171EBA28D7Q36902164-8B37B535-3FC7-47E0-9670-6D5E34375119Q36956184-7D52BA2A-E09A-4CBD-ABBB-A13A30C4FEEDQ37185640-6485EAD1-7A47-487A-8BA8-627CD09F462BQ37407284-F936EE9F-DAC4-4DF8-BACF-93D8706A4238Q37712723-0A7DC457-7D2A-4652-8846-15720395995FQ37959310-CFA0C334-CBF7-4E02-8A52-F5A1723A1617Q38262690-0FEEEB0B-3BF6-4B7B-83F9-D215750297CCQ38551398-26A39F40-1E4B-478F-9D66-56A93DB17A99Q38701055-48F73FAE-0F35-46AE-B857-B611E2F4E12FQ38701186-84882C82-4AD0-49BE-A81C-F766B9AEA224Q38708452-BF730E98-DF7C-4421-8DA3-EDC95A786C0EQ38793073-693220F2-5015-4892-95CD-C80A2D29767DQ39181270-8CF0082E-C9DB-42AA-B642-B0010088BF4EQ39217922-718D278F-1E21-401E-A8B4-11DF0CAB9133Q40140411-4D8FE118-CCB3-4D7D-87EB-E8EE78BBAA5AQ41526695-8781CBA0-621C-431A-8CBB-F2D682EC3A9DQ44728742-7AAF4807-9096-42A3-8338-AECE44DE9CB1Q46313886-4674196E-5050-4D78-AAE1-07F7CBF00484Q46872819-610BDF06-7463-47A7-B994-FD9D190B4145Q47883352-7BCC42A2-FC00-489F-89FD-2D771487B3D8Q47907429-DEC4A4E8-D49E-4D28-8108-F9045FF75182Q48228453-337CF353-58F3-48A5-BC97-1BCF5EAD87B3Q48281779-F0EADDF1-B81C-4560-AF27-78F4537EF828Q48381628-E75387C2-7FD3-4A11-8F1A-86FF04D09ED7Q49087870-D8425366-9B58-4335-AB3F-155B22F61BA2
P2860
Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Astrogliosis in amyotrophic la ...... peutic potential of astrocytes
@en
Astrogliosis in amyotrophic la ...... eutic potential of astrocytes.
@nl
type
label
Astrogliosis in amyotrophic la ...... peutic potential of astrocytes
@en
Astrogliosis in amyotrophic la ...... eutic potential of astrocytes.
@nl
prefLabel
Astrogliosis in amyotrophic la ...... peutic potential of astrocytes
@en
Astrogliosis in amyotrophic la ...... eutic potential of astrocytes.
@nl
P2860
P1433
P1476
Astrogliosis in amyotrophic la ...... peutic potential of astrocytes
@en
P2093
Jeffrey A Johnson
Marcelo R Vargas
P2860
P2888
P304
P356
10.1016/J.NURT.2010.05.012
P577
2010-10-01T00:00:00Z
P5875
P6179
1022588859